Eng C - Search Results

1

Protean PTEN: form and function.

Waite KA, Eng C. Waite KA, et al. Among authors: eng c. Am J Hum Genet. 2002 Apr;70(4):829-44. doi: 10.1086/340026. Epub 2002 Mar 1. Am J Hum Genet. 2002. PMID: 11875759 Free PMC article. Review.

2

A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma.

Farley MN, Schmidt LS, Mester JL, Pena-Llopis S, Pavia-Jimenez A, Christie A, Vocke CD, Ricketts CJ, Peterson J, Middelton L, Kinch L, Grishin N, Merino MJ, Metwalli AR, Xing C, Xie XJ, Dahia PLM, Eng C, Linehan WM, Brugarolas J. Farley MN, et al. Among authors: eng c. Mol Cancer Res. 2013 Sep;11(9):1061-1071. doi: 10.1158/1541-7786.MCR-13-0111. Epub 2013 May 24. Mol Cancer Res. 2013. PMID: 23709298 Free PMC article.

3

PTEN mutations are common in sporadic microsatellite stable colorectal cancer.

Nassif NT, Lobo GP, Wu X, Henderson CJ, Morrison CD, Eng C, Jalaludin B, Segelov E. Nassif NT, et al. Among authors: eng c. Oncogene. 2004 Jan 15;23(2):617-28. doi: 10.1038/sj.onc.1207059. Oncogene. 2004. PMID: 14724591

4

Caveolin-1 and caveolin-2,together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis.

Aldred MA, Ginn-Pease ME, Morrison CD, Popkie AP, Gimm O, Hoang-Vu C, Krause U, Dralle H, Jhiang SM, Plass C, Eng C. Aldred MA, et al. Among authors: eng c. Cancer Res. 2003 Jun 1;63(11):2864-71. Cancer Res. 2003. PMID: 12782592

5

Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer.

Frisk T, Foukakis T, Dwight T, Lundberg J, Höög A, Wallin G, Eng C, Zedenius J, Larsson C. Frisk T, et al. Among authors: eng c. Genes Chromosomes Cancer. 2002 Sep;35(1):74-80. doi: 10.1002/gcc.10098. Genes Chromosomes Cancer. 2002. PMID: 12203792

6

Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma.

Whiteman DC, Zhou XP, Cummings MC, Pavey S, Hayward NK, Eng C. Whiteman DC, et al. Among authors: eng c. Int J Cancer. 2002 May 1;99(1):63-7. doi: 10.1002/ijc.10294. Int J Cancer. 2002. PMID: 11948493 Free article.

7

Increased PTEN expression due to transcriptional activation of PPARgamma by Lovastatin and Rosiglitazone.

Teresi RE, Shaiu CW, Chen CS, Chatterjee VK, Waite KA, Eng C. Teresi RE, et al. Among authors: eng c. Int J Cancer. 2006 May 15;118(10):2390-8. doi: 10.1002/ijc.21799. Int J Cancer. 2006. PMID: 16425225 Free article.

8

Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma.

Vanharanta S, Buchta M, McWhinney SR, Virta SK, Peçzkowska M, Morrison CD, Lehtonen R, Januszewicz A, Järvinen H, Juhola M, Mecklin JP, Pukkala E, Herva R, Kiuru M, Nupponen NN, Aaltonen LA, Neumann HP, Eng C. Vanharanta S, et al. Among authors: eng c. Am J Hum Genet. 2004 Jan;74(1):153-9. doi: 10.1086/381054. Epub 2003 Dec 18. Am J Hum Genet. 2004. PMID: 14685938 Free PMC article.

9

A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma.

Borrego S, Wright FA, Fernández RM, Williams N, López-Alonso M, Davuluri R, Antiñolo G, Eng C. Borrego S, et al. Among authors: eng c. Am J Hum Genet. 2003 Jan;72(1):88-100. doi: 10.1086/345466. Epub 2002 Dec 9. Am J Hum Genet. 2003. PMID: 12474140 Free PMC article.

10

The pressure rises: update on the genetics of phaeochromocytoma.

Maher ER, Eng C. Maher ER, et al. Among authors: eng c. Hum Mol Genet. 2002 Oct 1;11(20):2347-54. doi: 10.1093/hmg/11.20.2347. Hum Mol Genet. 2002. PMID: 12351569 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results